Key facts
- This page summarizes Katherine A. Eade's Form 3 filing for Vaxxinity, Inc..
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 10 Feb 2023, 18:06.
Katherine A. Eade - 01 Feb 2023 Form 3 Insider Report for Vaxxinity, Inc.
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 01 Feb 2023
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 10 Feb 2023, 18:06:48 UTC
- Prior SEC filing
- 26 May 2022
- Next SEC filing
- 23 May 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Rene Paula Molina, attorney-in-fact for Katherine Eade
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Katherine A. Eade filed Form 3 for Vaxxinity, Inc. on 10 Feb 2023.
Change
- Previous filing in this sequence was filed on 26 May 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Additional SEC filing notes
Filing notes and footnotes
Ownership status
The filing reports no beneficially owned securities.